BE1013713A6 - Systeme d'administration orale osmotique controlee pour medicament moderement soluble. - Google Patents

Systeme d'administration orale osmotique controlee pour medicament moderement soluble. Download PDF

Info

Publication number
BE1013713A6
BE1013713A6 BE2001/0666A BE200100666A BE1013713A6 BE 1013713 A6 BE1013713 A6 BE 1013713A6 BE 2001/0666 A BE2001/0666 A BE 2001/0666A BE 200100666 A BE200100666 A BE 200100666A BE 1013713 A6 BE1013713 A6 BE 1013713A6
Authority
BE
Belgium
Prior art keywords
sep
coating
delivery system
drug delivery
oral osmotic
Prior art date
Application number
BE2001/0666A
Other languages
English (en)
French (fr)
Inventor
Uthli Dr
Menon
Dharmadhikari Dr
Karajgi Dr
Shrivastava Dr
Pratibha S Pilgaonkar
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Application granted granted Critical
Publication of BE1013713A6 publication Critical patent/BE1013713A6/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE2001/0666A 2001-02-02 2001-10-16 Systeme d'administration orale osmotique controlee pour medicament moderement soluble. BE1013713A6 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN119MU2001 IN190699B (https=) 2001-02-02 2001-02-02

Publications (1)

Publication Number Publication Date
BE1013713A6 true BE1013713A6 (fr) 2002-06-04

Family

ID=11097217

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2001/0666A BE1013713A6 (fr) 2001-02-02 2001-10-16 Systeme d'administration orale osmotique controlee pour medicament moderement soluble.

Country Status (4)

Country Link
US (1) US6534090B2 (https=)
BE (1) BE1013713A6 (https=)
IN (1) IN190699B (https=)
WO (1) WO2002060414A1 (https=)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1042981B (zh) * 1999-01-29 2006-07-28 高超明智公司 小型盘支架和夹持器
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20030175346A1 (en) * 2002-02-01 2003-09-18 Anne Billotte Osmotic delivery system
US6620900B2 (en) * 2002-02-07 2003-09-16 Isp Investments Inc. Proliferous copolymer of vinyl pyrrolidone and vinyl acetate
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
US8293799B2 (en) * 2003-12-29 2012-10-23 Osmotica Keresleedelmo és Szolgáltató KFT Osmotic device containing a venlafaxine salt and a salt having an ion in common
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
WO2006070406A1 (en) * 2004-12-29 2006-07-06 J.B. Chemicals & Pharmaceuticals Ltd Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
US8030260B2 (en) 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
US7405186B2 (en) * 2005-03-25 2008-07-29 Chemsil Silicones, Inc. Lubricant compositions, condom products and methods of making same
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
EP1929073A4 (en) * 2005-09-27 2010-03-10 Amunix Inc PROTEIN MEDICAMENT AND ITS USE
US7855279B2 (en) * 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
JP5738516B2 (ja) 2005-12-30 2015-06-24 ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド 心機能改善のためのニューレグリンの徐放
US8933197B2 (en) * 2007-08-15 2015-01-13 Amunix Operating Inc. Compositions comprising modified biologically active polypeptides
US8372431B2 (en) * 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
WO2010034688A2 (de) * 2008-09-25 2010-04-01 Basf Se Verwendung von copolymeren auf basis von polyethern und vinylmonomeren als bindemittel für feste wirkstoffhaltige dosierungsformen
CA2748314C (en) 2009-02-03 2018-10-02 Amunix Operating Inc. Extended recombinant polypeptides and compositions comprising same
SI2440241T1 (sl) 2009-06-08 2017-11-30 Amunix Operating Inc. Polipeptidni rastni hormoni in postopki za njihovo izdelavo in uporabo
JP5839597B2 (ja) 2009-06-08 2016-01-06 アムニクス オペレーティング インコーポレイテッド グルコース調節ポリペプチド並びにその作成及び使用方法
AU2010290131C1 (en) 2009-08-24 2015-12-03 Amunix Operating Inc. Coagulation factor VII compositions and methods of making and using same
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US20140302138A1 (en) 2011-10-14 2014-10-09 Micro Labs Limited Extended release pharmaceutical compositions containing carbamazepine
BR112014020694A2 (pt) 2012-02-15 2018-05-08 Amunix Operating Inc. proteína de fusão do fator viii compreendendo polipeptídeo do fator viii fusionado a polipeptí-deo recombinante estendido (xten) e seu método de fabricação, ácido nucleico, vetores, célula hospedeira, bem como composição farmacêutica e seu uso no tratamento de coagulopatia, episódio de hemorragia e hemofilia a
CA2864126A1 (en) 2012-02-15 2013-08-22 Biogen Idec Ma Inc. Recombinant factor viii proteins
EP2869911A4 (en) 2012-07-09 2016-05-11 Fosmo Med Inc DEVICES WITH MEMBRANE-EDUCED FORWARD OSMOSIS
US9394327B1 (en) * 2013-03-15 2016-07-19 The Trustees Of California State University Nucleoside crystals, crystal nucleation and growth control with antifreeze proteins
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
US10548953B2 (en) 2013-08-14 2020-02-04 Bioverativ Therapeutics Inc. Factor VIII-XTEN fusions and uses thereof
BR112018002150A2 (pt) 2015-08-03 2018-09-18 Bioverativ Therapeutics Inc proteínas de fusão do fator ix e métodos de fabricação e uso das mesmas
KR20230137362A (ko) 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
IL319473A (en) 2016-12-02 2025-05-01 Bioverativ Therapeutics Inc Methods for treating hemophilic arthritis using chimeric blood clotting factors
CN108125922A (zh) * 2018-01-14 2018-06-08 上海安必生制药技术有限公司 一种卡马西平口服缓释制剂及其制备方法
BR112020022164A2 (pt) 2018-05-18 2021-02-02 Bioverativ Therapeutics Inc. métodos de tratamento de hemofilia a
JP2023531494A (ja) 2020-06-25 2023-07-24 アムニクス ファーマシューティカルズ， インコーポレイテッド Ｈｅｒ－２標的化二重特異性組成物ならびにその作製および使用のための方法
EP4422607A4 (en) 2021-10-25 2025-09-03 Aquestive Therapeutics Inc ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111202A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4553973A (en) 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
NL8204205A (nl) * 1982-10-29 1984-05-16 Dsm Resins Bv Polyester en de toepassing daarvan in poederlak.
GB2150830B (en) 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
USRE34990E (en) 1986-08-07 1995-07-04 Ciba-Geigy Corporation Oral therapeutic system having systemic action
ES2039287T3 (es) * 1987-01-14 1993-09-16 Ciba-Geigy Ag Procedimiento para la obtencion de un sistema terapeutico peroral para productos activos dificilmente solubles.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use

Also Published As

Publication number Publication date
WO2002060414A1 (en) 2002-08-08
IN190699B (https=) 2003-08-16
US6534090B2 (en) 2003-03-18
US20030008006A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
BE1013713A6 (fr) Systeme d'administration orale osmotique controlee pour medicament moderement soluble.
BE1014328A7 (fr) Composition pharmaceutique orale a liberation controlee.
EP1194125B1 (fr) Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
EP2435030B1 (fr) Compositions pharmaceutiques flottantes à libération contrôlée
EP1007005B1 (fr) Compositions pharmaceutiques pour la liberation controlee de substances actives
EP1492511B1 (fr) Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
EP1121099B1 (fr) Composition pharmaceutique a residence gastrique et a liberation controlee
EP1496869B1 (fr) Particules enrobees a liberation prolongee et comprimes les contenant
EP1524968B1 (fr) Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
RU2542461C2 (ru) Фармацевтические композиции, содержащие диацереин
EP0300897B1 (fr) Dispositif à libération contrôlée qui fournit une délivrance continue d'un principe actif de manière contrôlée et compositions à particules multiples contenant de tels dispostifs
WO2000007568A1 (fr) Procede de fabrication de particules de gabapentine ou de pregabaline enrobees
WO2003053417A2 (fr) Procede de fabrication d'un comprime incluant un analgesique de type morphinique et comprime obtenu
CA2197234A1 (fr) Composition permettant une liberation selective d'un principe actif
EP1492531A2 (fr) Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline
FR2930147A1 (fr) Forme orale solide dotee d'un double profil de liberation
BE1001706A3 (fr) Forme d'administration solide, a desagregation rapide, du diclofenac.
BE1015413A6 (fr) Systeme de delivrance orale controlee d'un medicament.
WO2001051033A1 (fr) Compositions pharmaceutiques solides pour la liberation controlee de substances actives
CA2577361C (fr) Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif
BE1015514A6 (fr) Systeme osmotique de delivrance controlee d'un medicament oral.
WO1995016451A1 (fr) Comprimes a liberation controlee de 4-asa
EP1879559A2 (fr) Medicament oral a base d'inhibiteur de pompe a protons
EP1850835A1 (fr) Forme pharmaceutique orale de losartan
FR2882260A1 (fr) Forme pharmaceutique orale multimicroparticulaire a liberation modifiee d'antagonistes des recepteurs de l'angiotensine ii

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20031031